UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 190

Sortiert nach

Experience of switching from a daily to a less frequent administration of injection treatments

PloS one, 2022-11, Vol.17 (11), p.e0278293-e0278293

2022

Volltextzugriff (PDF)

Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations

Pain (Amsterdam), 2013-11, Vol.154 (11), p.2287

2013

Volltextzugriff (PDF)

Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study

The journal of clinical endocrinology and metabolism, 2022-06, Vol.107 (7), p.e2717-e2728

2022

Volltextzugriff (PDF)

Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States

Pain medicine (Malden, Mass.), 2011-04, Vol.12 (4), p.657-667

2011

Volltextzugriff (PDF)

Medical outcomes associated with prescription opioid abuse via oral and non-oral routes of administration

Drug and alcohol dependence, 2017-06, Vol.175, p.140-145

2017

Volltextzugriff (PDF)

The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and Poisoning

Journal of managed care & specialty pharmacy, 2019-01, Vol.25 (1), p.18

2019

Volltextzugriff (PDF)

A Model to Identify Patients at Risk for Prescription Opioid Abuse, Dependence, and Misuse

Pain medicine (Malden, Mass.), 2012-09, Vol.13 (9), p.1162-1173

2012

Volltextzugriff (PDF)

Prevalence and cost of diagnosed opioid abuse in a privately insured population in the United States

Journal of opioid management, 2013-05, Vol.9 (3), p.161

2013

Volltextzugriff (PDF)

A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients

Journal of opioid management, 2013-03, Vol.9 (2), p.139

2013

Volltextzugriff (PDF)

Positive subjective measures in abuse liability studies and real-world nonmedical use: Potential impact of abuse-deterrent opioids on rates of nonmedical use and associated healthcare costs

Journal of opioid management, 2015-05, Vol.11 (3), p.199

2015

Volltextzugriff (PDF)

Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting

Journal of opioid management, 2011-11, Vol.7 (6), p.467

2011

Volltextzugriff (PDF)

The content validation of the Self-Reported Misuse, Abuse and Diversion of Prescription Opioids (SR-MAD) instrument for use in patients with acute or chronic pain

Current medical research and opinion, 2017-06, Vol.33 (6), p.1067-1076

2017

Volltextzugriff (PDF)

Evaluating the abuse potential of opioids and abuse-deterrent -opioid formulations: A review of clinical study methodology

Journal of opioid management, 2017-11, Vol.13 (6), p.485

2017

Volltextzugriff (PDF)

Assessing the impact of abuse-deterrent opioids (ADOs): identifying epidemiologic factors related to new entrants with low population exposure

Postgraduate medicine, 2017-01, Vol.129 (1), p.12-21

2017

Volltextzugriff (PDF)

Self-reports of prescription opioid abuse and diversion among recreational opioid users in a Canadian and a United States city

Journal of opioid management, 2015-11, Vol.11 (6), p.463

2015

Volltextzugriff (PDF)

Measurement of drug-liking in abuse potential studies: A comparison of bipolar vs. unipolar visual analog scales

Drug and alcohol dependence, 2014-07, Vol.140, p.e188-e188

2014

Volltextzugriff (PDF)

A double‐blind, randomized, placebo‐controlled trial of a diazepam auto‐injector administered by caregivers to patients with epilepsy who require intermittent intervention for acute repetitive seizures

Epilepsia (Copenhagen), 2013-11, Vol.54 (11), p.1968-1976

2013

Volltextzugriff (PDF)

Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain

Postgraduate medicine, 2017-01, Vol.129 (1), p.5-11

2017

Volltextzugriff (PDF)

Prevalence of Prescription Opioid Misuse/Abuse as Determined by International Classification of Diseases Codes: A Systematic Review

Journal of pain & palliative care pharmacotherapy, 2016-10, Vol.30 (4), p.258-268

2016

Volltextzugriff (PDF)

Economic Burden of Prescription Opioid Misuse and Abuse: A Systematic Review

Journal of pain & palliative care pharmacotherapy, 2015-10, Vol.29 (4), p.388-400

2015

Volltextzugriff (PDF)

Assessing aberrant behaviors related to prescription drugs in the patient population: Recent studies, methodologies and findings

Drug and alcohol dependence, 2015-11, Vol.156, p.e202-e202

2015

Volltextzugriff (PDF)

The Abuse Potential of Remoxy®, an Extended-Release Formulation of Oxycodone, Compared with Immediate- and Extended-Release Oxycodone

Pain medicine (Malden, Mass.), 2011-04, Vol.12 (4), p.618-631

2011

Volltextzugriff (PDF)

Safety and effectiveness of long‐term treatment with diazepam auto‐injector administered by caregivers in an outpatient setting for the treatment of acute repetitive seizures

Epilepsia (Copenhagen), 2014-09, Vol.55 (9), p.1444-1451

2014

Volltextzugriff (PDF)

Modeling the potential impact of abuse-deterrent opioids on medical resource utilization

Journal of medical economics, 2019-10, Vol.22 (10), p.1073-1079

2019

Volltextzugriff (PDF)

Response to Letter by Dr. Ruan

Pain medicine (Malden, Mass.), 2013-01, Vol.14 (1), p.161-162

2013

Volltextzugriff (PDF)

1 – 25 von 190

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(155)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(123)
Life Sciences & Biomedicine
(92)
Humans
(81)
Male
(50)
Female
(42)
Adult
(35)
Middle Aged
(35)
Biological And Medical Sciences
(23)
Aged
(22)
Neurosciences & Neurology
(19)
Adolescent
(18)
Child
(17)
General & Internal Medicine
(17)
Medical Sciences
(17)
Medicine, General & Internal
(17)
Physical Sciences
(16)
Young Adult
(15)
Clinical Neurology
(14)
Analgesics, Opioid - Adverse Effects
(13)
Multidisciplinary Sciences
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Experience of switching from a daily to a less frequent administration of injection treatments

Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations

Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study

Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States

Medical outcomes associated with prescription opioid abuse via oral and non-oral routes of administration

The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and Poisoning

A Model to Identify Patients at Risk for Prescription Opioid Abuse, Dependence, and Misuse

Prevalence and cost of diagnosed opioid abuse in a privately insured population in the United States

A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients

Positive subjective measures in abuse liability studies and real-world nonmedical use: Potential impact of abuse-deterrent opioids on rates of nonmedical use and associated healthcare costs

Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting

The content validation of the Self-Reported Misuse, Abuse and Diversion of Prescription Opioids (SR-MAD) instrument for use in patients with acute or chronic pain

Evaluating the abuse potential of opioids and abuse-deterrent -opioid formulations: A review of clinical study methodology

Assessing the impact of abuse-deterrent opioids (ADOs): identifying epidemiologic factors related to new entrants with low population exposure

Self-reports of prescription opioid abuse and diversion among recreational opioid users in a Canadian and a United States city

Measurement of drug-liking in abuse potential studies: A comparison of bipolar vs. unipolar visual analog scales

A double‐blind, randomized, placebo‐controlled trial of a diazepam auto‐injector administered by caregivers to patients with epilepsy who require intermittent intervention for acute repetitive seizures

Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain

Prevalence of Prescription Opioid Misuse/Abuse as Determined by International Classification of Diseases Codes: A Systematic Review

Economic Burden of Prescription Opioid Misuse and Abuse: A Systematic Review

Assessing aberrant behaviors related to prescription drugs in the patient population: Recent studies, methodologies and findings

The Abuse Potential of Remoxy®, an Extended-Release Formulation of Oxycodone, Compared with Immediate- and Extended-Release Oxycodone

Safety and effectiveness of long‐term treatment with diazepam auto‐injector administered by caregivers in an outpatient setting for the treatment of acute repetitive seizures

Modeling the potential impact of abuse-deterrent opioids on medical resource utilization

Response to Letter by Dr. Ruan

Suchergebnisse filtern